Oestrogen Receptor Positive Advanced Breast Cancer

1 clinical trials · Condition

Record	Firm	Date
An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis (NCT01743560)	Novartis Pharmaceuticals	2013-01-31

Every clearance here is in the API, with alerts when new ones post.